Home       Company     Technology     Services     Resources      Partnerships     Career     Contact Us      



 


MISSION
→Democratization
Our mission is to help diagnoses and treatments adapt to the genetic changes of each person.
Our primary goal is to augment “omics” data (genomic, proteomic, and metabolomic, etc.) for South American haplogroups and other minority populations in the world’s largest biomedical databases. In turn, this information will allow the development and distribution of new biopharmaceutical drugs and vaccines (whose design is based on genomic diversity), to these populations.
 


VISION
→Be a Market Leader
To create life-changing diagnostics and therapies for patients with severe diseases.
We strongly believe that “deep AI-based profiles” of patients, including digital medical records and clinical genetic sequencing, can provide early warning signs of disease and reduce healthcare costs.


The Problem
Diagnostic odyssey

Patients carrying rare or undiagnosed diseases take on average 6 years to reach a final diagnosis, after having had multiple referrals and encounters with specialists and a battery of often unnecessary investigations. This odyssey represents not only a health risk, but also an emotional and financial burden.
Lack of diversity in
genomic databases

Unfavored populations are currently underrepresented in genomic databases. This underscores the consolidation of precision medicine, drug development and repositioning within these groups of people.


The Solution
→ Genome-as-a-Service
 
Clinical grade ultra high throw-put whole genome sequencing (WGS) and panels for most prevalent diseases (i.e., diabetes, cardiovascular, cancer) as well as rare diseases (i.e., Prader-Willi, Chagas, etc.).
→ Omics Biobank
 
Omics database (underrepresented haplogroups) for the development of new drugs and repositioning of existing or failed ones.


Towards
Genomic Equity









by Statusmkt.com